Balance Sheet for CNBXD

	CNBX Pharmaceuticals Inc. (CNBXD)
	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014
Balance Sheet Date		2025-Nov-30	2025-Aug-31	2025-May-31	2025-Feb-28	2024-Nov-30	2024-Aug-31	2024-May-31	2024-Feb-29										2021-Aug-31	2021-May-31	2021-Feb-28	2020-Nov-30	2020-Aug-31	2020-May-31	2020-Feb-29	2019-Nov-30	2019-Aug-31	2019-May-31	2019-Feb-28	2018-Nov-30	2018-Aug-31	2018-May-31	2018-Feb-28	2017-Nov-30	2017-Aug-31	2017-May-31	2017-Feb-28	2016-Nov-30	2016-Aug-31	2016-May-31	2016-Feb-29	2015-Nov-30	2015-Aug-31	2015-May-31	2015-Feb-28	2014-Nov-30	2014-Aug-31	2014-May-31	2014-Feb-28
Fiscal Period		Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024										Q4-FY2021	Q3-FY2021	Q2-FY2021	Q1-FY2021	Q4-FY2020	Q3-FY2020	Q2-FY2020	Q1-FY2020	Q4-FY2019	Q3-FY2019	Q2-FY2019	Q1-FY2019	Q4-FY2018	Q3-FY2018	Q2-FY2018	Q1-FY2018	Q4-FY2017	Q3-FY2017	Q2-FY2017	Q1-FY2017	Q4-FY2016	Q3-FY2016	Q2-FY2016	Q1-FY2016	Q4-FY2015	Q3-FY2015	Q2-FY2015	Q1-FY2015	Q4-FY2014	Q3-FY2014	Q2-FY2014
Total Assets		11,162$	18,437$	18,615$	50,660$	22,308$	31,383$	80,027$	163,917$		499,039$								3,078,961$	3,801,943$	4,966,560$	1,698,531$	2,219,311$	5,528,176$	3,571,134$	6,461,740$	15,183,166$	19,771,717$	18,344,179$	9,483,374$	3,184,905$	3,159,745$	3,722,764$	3,061,683$	3,637,756$	3,462,824$	591,642$	282,959$	23,716$	92,504$	84,280$	22,633$	28,704$	29,994$	49,923$	88,636$	114,222$	0$	1,076$
Total Current Assets		11,162$	18,437$	18,615$	50,660$	22,308$	31,383$	80,027$	163,917$		224,308$								1,590,847$	2,126,916$	1,505,002$	352,605$	929,910$	1,589,050$	2,301,820$	3,041,099$	4,306,934$	5,204,074$	5,942,353$	7,238,168$	1,620,852$	2,330,870$	2,977,805$	2,941,975$	3,517,378$	3,372,796$	589,056$	281,604$	22,093$	90,549$	81,910$	19,848$	25,503$	25,921$	45,484$	83,829$	112,757$
Cash and Cash Equivalents		7,703$	15,111$	13,648$	45,675$	17,339$	26,416$	73,406$	37,142$		129,696$								1,386,472$	1,968,291$	1,334,409$	184,031$	777,611$	357,629$	586,972$	319,344$	265,982$	493,501$	5,167,840$	6,579,908$	1,393,608$	2,215,362$	2,864,251$	2,888,250$	1,393,608$	3,190,303$	567,217$	278,151$	19,127$	88,502$	77,397$	9,560$	25,229$	21,551$	8,211$	32,468$	98,768$	0$	1,076$
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets		0$	0$	0$	0$	0$	0$	0$	0$		274,731$								1,488,114$	1,675,027$	3,461,558$	1,345,926$	1,289,401$	3,939,126$	1,269,314$	3,420,641$	10,876,232$	14,567,643$	12,401,826$	2,245,206$	1,564,053$	828,875$	744,959$	119,708$	120,378$	90,028$	2,586$	1,355$	1,623$	1,955$	2,370$	2,785$	3,201$	4,073$	4,439$	4,807$	1,465$	0$	1,076$
Goodwill
Other Intangible Assets
Physical Assets											274,731$								642,896$	693,870$	749,816$	806,317$	862,879$	910,818$	913,226$	960,508$	1,002,286$	1,018,254$	994,470$	1,004,206$	974,331$	828,875$	744,959$	119,708$	120,378$	90,028$	2,586$	1,355$	1,623$	1,955$	2,370$	2,785$	3,201$	4,073$	4,439$	4,807$	1,465$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities		2,584,133$	2,514,730$	2,556,020$	2,621,140$	2,536,640$	2,511,363$	2,534,398$	2,522,451$		2,516,328$								1,273,046$	1,470,000$	1,184,008$	442,687$	454,787$	3,017,015$	455,642$	400,456$	438,874$	454,135$	376,182$	412,741$	539,382$	523,344$	474,756$	639,754$	6,576,389$	586,212$	769,508$	513,442$	491,164$	491,431$	482,511$	341,515$	338,330$	203,308$	97,013$	78,521$	74,140$	3,798$	51,000$
Total Current Liabilities		2,584,133$	2,514,730$	2,556,020$	2,621,140$	2,536,640$	2,511,363$	2,534,398$	2,522,451$		2,516,328$								1,273,046$	1,470,000$	1,184,008$	442,687$	454,787$	430,138$	419,642$	440,456$	438,874$	454,135$	376,180$	412,739$	539,382$	523,344$	474,756$	639,754$	699,123$	586,212$	769,508$	513,442$	491,164$	491,431$	482,511$	341,515$	338,330$	203,308$	97,013$	78,521$	74,140$	3,798$	51,000$
Accounts Payable
Short Term Debt
Short Term Capital Lease Obligations
Other Current Liabilities
Total Noncurrent Liabilities		0$	0$	0$	0$	0$	0$	0$	0$		0$								0$	0$	0$	0$	0$	2,586,877$	36,000$	(40,000$)	0$	0$	2$	2$	0$	0$	0$	0$	5,877,266$	0$	0$	0$	0$	0$	0$	0$	0$	0$	0$	0$	0$	0$	0$
Long Term Debt
Long Term Capital Lease Obligations
Other Noncurrent Liabilities																																													0$	0$	0$	0$
Total Equity		(2,572,971$)	(2,496,293$)	(2,537,405$)	(2,570,480$)	(2,514,332$)	(2,479,980$)	(2,454,371$)	(2,358,534$)	(2,094,929$)	(2,017,289$)	(1,909,442$)	(2,011,531$)	(1,974,293$)	1,632,311$				1,805,915$	2,331,943$	3,782,552$	1,255,844$	1,764,524$	2,511,161$	3,115,492$	6,061,284$	14,744,292$	19,317,582$	17,967,997$	9,070,633$	2,645,523$	2,636,401$	3,248,008$	2,421,929$	(2,938,633$)	2,876,612$	(177,866$)	(230,483$)	(467,448$)	(398,927$)	(398,231$)	(318,882$)	(309,626$)	(173,314$)	(47,090$)	410,115$	40,082$	(3,798$)	(49,924$)
Equity to Minority
Equity to Common Shareholders		(2,572,971$)	(2,496,293$)	(2,537,405$)	(2,570,480$)	(2,514,332$)	(2,479,980$)	(2,454,371$)	(2,358,534$)	(2,094,929$)	(2,017,289$)	(1,909,442$)	(2,011,531$)	(1,974,293$)	1,632,311$				1,805,915$	2,331,943$	3,782,552$	1,255,844$	1,764,524$	2,511,161$	3,115,492$	6,061,284$	14,744,292$	19,317,582$	17,967,997$	9,070,633$	2,645,523$	2,636,401$	3,248,008$	2,421,929$	(2,938,633$)	2,876,612$	(177,866$)	(230,483$)	(467,448$)	(398,927$)	(398,231$)	(318,882$)	(309,626$)	(173,314$)	(47,090$)	410,115$	40,082$	(3,798$)	(49,924$)
Additional Paid-In Capital		22,733,805$	22,716,687$	22,571,611$	22,484,674$	22,471,309$	22,471,309$	22,436,334$	22,401,539$		22,239,652$								17,063,363$	16,772,511$	15,405,295$	15,405,295$	15,372,311$	15,372,310$	15,372,316$	15,270,250$	15,300,250$	15,418,827$	14,509,120$	14,225,814$	9,840,420$	9,188,824$	8,928,691$	6,467,637$	6,446,839$	5,281,841$	1,882,299$	1,616,443$	1,108,148$	1,108,168$	988,823$	1,005,297$	959,362$	881,594$	863,603$	863,603$	767,808$	557,157$	461,265$
Retained Earnings		(25,382,095$)	(25,268,376$)	(25,118,267$)	(25,058,540$)	(24,988,752$)	(24,954,400$)	(24,893,816$)	(24,763,184$)		(24,259,202$)								(16,825,718$)	(16,144,568$)	(14,820,793$)	(14,286,038$)	(13,631,271$)	(12,899,543$)	(12,173,869$)	(11,306,002$)	(6,163,807$)	(4,770,535$)	(4,223,086$)	(7,952,753$)	(7,296,777$)	(6,564,505$)	(5,692,732$)	(4,057,664$)	(3,520,160$)	(2,417,061$)	(2,171,632$)	(1,733,333$)	(1,586,319$)	(1,517,798$)	(1,491,319$)	(1,334,394$)	(1,279,138$)	(1,074,218$)	(920,377$)	(865,409$)	(737,751$)	(569,131$)	(513,277$)
Treasury Stock
Capital Lease Obligations